Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Alport syndrome

Alport syndrome

Part of Nephritis

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Alport syndrome

4 trials tracked for Alport syndrome: 1 in phase 3 or 4 and 1 with published results. The most-cited published study has 156 citations.

4Trials tracked
1Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 3 1 Phase 2 2 Other / NA 1
  1. Phase 3 A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL Completed · 156 cited
  2. Phase 2 A Study of ELX-02 in Patients With Alport Syndrome Completed
  3. Phase 2 A Study to Evaluate Setanaxib in Patients With Alport Syndrome Completed
  4. N/A A Prospective Study of Microalbuminuria in Untreated Boys With Alport Syndrome Completed

Showing the 4 most-cited and recently-updated of 4 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Case report confirms X-linked Alport syndrome diagnosis in a young girl with family history
Pediatrics Sys. Review
Case report confirms X-linked Alport syndrome diagnosis in a young girl with family history Early testing confirms X-linked Alport syndrome in a toddler
This case report describes a 4-year-2-month-old girl with X-linked Alport syndrome who underwent renal biopsy and genetic testing. The diagn…
A young girl with a family history of kidney disease received a quick diagnosis through biopsy and genetic tests.
Frontiers May 27, 2026
Systematic Review Examines Therapeutic Strategies Targeting Renal ELD in Kidney Diseases
Diabetes & Endocrinology Sys. Review
Systematic Review Examines Therapeutic Strategies Targeting Renal ELD in Kidney Diseases Kidney Damage May Start With Fat in the Wrong Places
This systematic review summarizes mechanisms and therapeutic strategies targeting renal ELD across kidney diseases, including diabetic and…
This research explains how fat in the wrong kidney cells causes harm, opening new paths for prevention and treatment.
Frontiers Apr 22, 2026